AMG 386 and Abiraterone for Advanced Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 8, 2012

Primary Completion Date

April 20, 2017

Study Completion Date

July 1, 2018

Conditions
Prostatic NeoplasmsProstate CancerNeoplasm, ProstateNeoplasm,Prostatic
Interventions
DRUG

AMG 386

AMG 386 dose will be calculated using the subjects actual body weight (Kg). Supplied in 240 mg v will be administered as an intravenous (IV) infusion using an intravenous infusion pump given over a 60-minute period.

DRUG

Abiraterone

A 1,000 mg dose of abiraterone should be taken orally once daily

DRUG

Prednisone

Prednisone should be taken orally either, at 5mg twice a day for each dose or 10 mg once a day a patients preference.

Trial Locations (2)

19111

Fox Chase Cancer Center, Philadelphia

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT01553188 - AMG 386 and Abiraterone for Advanced Prostate Cancer | Biotech Hunter | Biotech Hunter